For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) executive director, Lauren Aronson, today released the following statement after the U.S. House Oversight and Reform and U.S. Senate Finance Committees held their first hearings on drug pricing: “We appreciate the commitment of Senate Finance Committee […]
For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] SHOT: Pfizer & Novartis Introduce Minor Price Hikes On A Small Portion Of Their Drugs: Pfizer And Novartis Left The Prices To The “Vast Majority” Of Their Portfolios Unchanged. “Pharma giants Pfizer and Novartis have officially raised prices on dozens of drugs, according to data from […]
In advance of the House and Senate hearings on January 29, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is rolling out a new blog series on what lawmakers can expect to hear from pharmaceutical companies. Yesterday, we looked at the three biggest makers of insulin in the world, Eli Lily, Novo Nordisk and Sanofi. […]
In advance of the hearing on January 29, 2019, the Campaign for Sustainable Rx Pricing (CSRxP) is rolling out a new blog series on what lawmakers can expect to hear from pharmaceutical companies. Yesterday, we looked at AbbVie, Celgene and Mallinckrodt. Today, we will look at the rhetoric and track records of Eli Lilly, Novo […]
For Immediate Release: Contact: Lauren Blair (201) 213-5004 [email protected] With 80 percent of Americans viewing the drug pricing crisis as the top priority for Congress to tackle this year, it should not come as a surprise that the focus of the U.S. House of Representatives Committee on Oversight and Government Reform’s first oversight hearing is out-of-control drug […]
The Campaign for Sustainable Rx Pricing (CSRxP) Communications Director Lauren Blair today issued the following statement applauding the launch of the Coalition Against Patent Abuse, a new multi-stakeholder organization working to protect patients from Big Pharma’s patent abuses, and encourage more generic and biosimilar competition: “Big Pharma knows how to game the patent system to […]
With ‘taking action to lower drug prices’ becoming Americans’ top priority for the 116th Congress, the Campaign for Sustainable Rx Pricing (CSRxP) launched a new website to help members and their staff better understand the drug price crisis and the bipartisan, market-based solutions needed to make drugs more affordable for all Americans. “Lowering prescription drug prices was […]
For Immediate Release Contact: Lauren Blair (201) 213-5004 [email protected] SHOT: Analysts Suggest Drug Makers Are Changing Their Ways: Analyst Says Industry Appears To Be “Self-Policing.” “Umer Raffat, an analyst at Everscore ISI, said the increases this year appear to be modest, similar to the past couple of years, as the industry adjusts to pressures on […]
For Immediate Release Contact: Lauren Blair (201) 213-5004 [email protected] The Campaign for Sustainable Rx Pricing (CSRxP) Communications Director Lauren Blair issued the following statement in response to a new study from RX Savings Solutions that found more than three dozen pharmaceutical companies raised the prices on hundreds of medications earlier this week: “Just like that, […]
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued the following statement in response to a report that 30 pharmaceutical companies are expected to increase drug prices next month, which follows Pfizer’s earlier announcement it would revert back to “business as normal”: “This news shouldn’t come as a shock to anyone. Big Pharma has blinders on and the […]